Impact Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Impact Capital Partners's AMGN Position: Q3 2026 in Review
Impact Capital Partners increased its Amgen (AMGN) stake by 2.7% in Q3 2026, buying an estimated $9.17K and bringing the position to 874 shares worth $368K. The position accounts for 0.1% of the portfolio, ranked #179.
Impact Capital Partners first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Impact Capital Partners held 874 shares of Amgen worth $368K as of Q3 2026.
- Impact Capital Partners bought 23 Amgen shares in Q3 2026, an estimated $9.17K.
- Amgen made up 0.1% of Impact Capital Partners's portfolio in Q3 2026, its #179 holding.
- Impact Capital Partners first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Impact Capital Partners's 13F filing for Q3 2026, filed 22 Oct 2026.